Literature DB >> 21856571

Neuroscience in Nazi Europe part I: eugenics, human experimentation, and mass murder.

Lawrence A Zeidman1.   

Abstract

The Nazi regime in Germany from 1933 to 1945 waged a veritable war throughout Europe to eliminate neurologic disease from the gene pool. Fueled by eugenic policies on racial hygiene, the Nazis first undertook a sterilization campaign against "mental defectives," which included neurologic patients with epilepsy and other disorders, as well as psychiatric patients. From 1939-41 the Nazis instead resorted to "euthanasia" of many of the same patients. Some neuroscientists were collaborators in this program, using patients for research, or using extracted brains following their murder. Other reviews have focused on Hallervorden, Spatz, Schaltenbrand, Scherer, and Gross, but in this review the focus is on neuroscientists not well described in the neurology literature, including Scholz, Ostertag, Schneider, Nachtsheim, and von Weizsäcker. Only by understanding the actions of neuroscientists during this dark period can we learn from the slippery slope down which they traveled, and prevent history from repeating itself.

Entities:  

Mesh:

Year:  2011        PMID: 21856571     DOI: 10.1017/s0317167100054068

Source DB:  PubMed          Journal:  Can J Neurol Sci        ISSN: 0317-1671            Impact factor:   2.104


  5 in total

1.  [German neurology and neurologists during the Third Reich: the aftermath].

Authors:  M Martin; H Fangerau; A Karenberg
Journal:  Nervenarzt       Date:  2016-08       Impact factor: 1.214

Review 2.  Historical review: the German Neurological Society and its honorary members (1952-1982).

Authors:  Michael Martin; Heiner Fangerau; Axel Karenberg
Journal:  Neurol Res Pract       Date:  2022-07-04

Review 3.  [Neurologists and neuroscientists during the "Third Reich": attempt at an assessment].

Authors:  Axel Karenberg; Heiner Fangerau; Michael Martin
Journal:  Nervenarzt       Date:  2020-02       Impact factor: 1.214

4.  Jumping on the Train of Personalized Medicine: A Primer for Non- Geneticist Clinicians: Part 3. Clinical Applications in the Personalized Medicine Area.

Authors:  Aihua Li; David Meyre
Journal:  Curr Psychiatry Rev       Date:  2014-05

5.  Renaming of Hallervorden-Spatz disease: the second man behind the name of the disease.

Authors:  Luca Voges; Andreas Kupsch
Journal:  J Neural Transm (Vienna)       Date:  2021-10-16       Impact factor: 3.575

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.